Mukdahan International Hospital Public Company Limited
0.79
THB
+0.03
(+3.95%)
ISIN
THC925010R17
Return %
Stock
S&P 500
1Y
-26.85
14.39
3Y
- -
81.42
5Y
- -
68.62
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Prapasri Suchantabutr
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Mukdahan Thailand
- Similar Companies
- Business
- Mukdahan International Hospital Public Company Limited (SET: HANN) is a Thailand-based healthcare provider that owns and operates a network of private hospitals and specialized medical centers in northeastern Thailand. Founded in 1995 and headquartered in Mukdahan, Thailand, the company traces its origins to the establishment of Dr. Hann Clinic in 1984 and provides comprehensive inpatient, outpatient, and critical care medical services across Thailand's Isan region and to cross-border international patients from neighboring Laos, particularly Savannakhet Province. The company operates through three primary hospital facilities—Mukdahan International Hospital, Dr. Hann Hospital, and Ruampat Yasothon Hospital—offering an aggregate registered capacity of 148 beds across more than 16 specialized medical centers and clinics. The company delivers a systematic range of medical healthcare services and diagnostic capabilities, comprising 24-hour emergency medicine and trauma care; general surgery, minimally invasive laparoscopic surgery, and orthopedic and joint surgery; urological surgery; general internal medicine and cardiology; nephrology and hemodialysis services, including arteriovenous fistula (AVF) and arteriovenous graft (AVG) vascular access procedures; obstetrics, gynecology, and women's health; pediatrics and child development care; neurology; ear, nose, and throat (ENT) treatments; physical therapy and rehabilitation; diagnostic imaging and radiology; clinical laboratory and pathology services; health screening and wellness check-ups; and inpatient hospital room accommodations and pharmaceutical dispensing. In recent strategic developments, the company completed its initial public offering (IPO) and listed its shares on the Market for Alternative Investment (mai) of the Stock Exchange of Thailand under the ticker symbol HANN in August 2025 to fund facility modernizations, procurement of advanced medical equipment, and debt repayment. Over the past two years, the company has expanded its hemodialysis capacity, enhanced specialized referral and cross-border patient liaison channels catering to Indochina medical tourists, and broadened its collaboration with private health insurers and Thailand's National Health Security Office (NHSO) welfare reimbursement schemes to drive patient volume growth across its regional hospital network.